117 related articles for article (PubMed ID: 16610076)
1. [Inhibition effect of topotecan on human myelodysplastic syndrome cells in vitro and in vivo].
Liu JQ; Zhang WF; Jin J; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 35(2):127-31. PubMed ID: 16610076
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Lu J; Jin J; Xu WL
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
[TBL] [Abstract][Full Text] [Related]
3. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of apoptosis protein inhibitor survivin and XIAP, in patients with myelodysplastic syndromes and in the cell line MUTZ-1].
Cai Z; Bao HY; Ludwig WD; Wuchter C
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):26-30. PubMed ID: 14990073
[TBL] [Abstract][Full Text] [Related]
5. Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner.
Huang J; Yang M; Liu H; Jin J
Acta Pharmacol Sin; 2008 Aug; 29(8):951-64. PubMed ID: 18664328
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition effect of fludarabine on the growth of myelodysplastic syndrome cell line MUTZ-1 and its mechanism].
Wu WJ; Cai Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 35(2):136-42. PubMed ID: 16610078
[TBL] [Abstract][Full Text] [Related]
7. [Effect of 5-aza-2'-deoxycytidine on cell of high-risk patients with myelodysplastic syndrome in vitro].
Tong HY; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):467-71. PubMed ID: 15363133
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferation in human EA.hy926 endothelial cells and inhibition of VEGF expression in PC-3 cells by topotecan.
Yang X; Zhang C; Ying M; Yang B; He Q
Pharmazie; 2007 Jul; 62(7):534-8. PubMed ID: 17718196
[TBL] [Abstract][Full Text] [Related]
9. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.
Tomicic MT; Christmann M; Kaina B
J Pharmacol Exp Ther; 2010 Jan; 332(1):316-25. PubMed ID: 19812371
[TBL] [Abstract][Full Text] [Related]
10. [Effects of sodium valproate on proliferation and apoptosis of human myelodysplastic syndromes cell line MUTZ-1].
Chen BA; Zhao HH; Gao C; Shao ZY; Xia GH; Dohner K
Ai Zheng; 2007 Dec; 26(12):1323-9. PubMed ID: 18076794
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of 2-methoxyestradiol-induced apoptosis in myelodysplastic syndrome MUTZ-1 cell line.
Xia GH; Chen BA; Shao ZY; Lu HX; Konstanze D; Hartmut D
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):296-301. PubMed ID: 17493335
[TBL] [Abstract][Full Text] [Related]
12. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
[TBL] [Abstract][Full Text] [Related]
13. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line.
Zhang J; Cheng C; He CL; Zhou YJ; Cao Y
Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767
[TBL] [Abstract][Full Text] [Related]
14. [Killing and proapoptotic effects of topoisomerase I inhibitor on K562 cells].
Chen XQ; Wan YF; Bai QX; Cao YX
Ai Zheng; 2002 Apr; 21(4):356-9. PubMed ID: 12452010
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo].
Lu J; Jin J
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386
[TBL] [Abstract][Full Text] [Related]
16. [Study of triptolide-induced apoptosis in MUTZ-1 cells and its allied mechanism].
Deng J; Jin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):434-9. PubMed ID: 15972136
[TBL] [Abstract][Full Text] [Related]
17. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells.
Huang J; Ding T; Yang M; Liu H; Sun X; Jin J
Int J Hematol; 2011 Apr; 93(4):482-493. PubMed ID: 21451957
[TBL] [Abstract][Full Text] [Related]
19. HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity.
Parmakhtiar B; Burger RA; Kim JH; Fruehauf JP
Mol Cancer Res; 2019 Aug; 17(8):1675-1686. PubMed ID: 31088908
[TBL] [Abstract][Full Text] [Related]
20. Combinational effect of topotecan and octreotide on murine leukemia cells in vivo and in vitro.
Dalezis P; Geromichalos GD; Voyatzi S; Trafalis D; Athanassiou AE; Koutsilieris M; Papageorgiou A
J BUON; 2006; 11(3):323-7. PubMed ID: 17309157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
